Home/Stocks/Financials

Monks Investment Trust PLC

MNKS.L·Financials·Market Cap £2.5b
Rank #252 of 280
Quantitative Model · 280 Stocks Analysed
£16.82
+12.13% YTD
52W: £13.66 - £16.96

Factor Analysis Summary

Editorial assessment generated from Monks Investment Trust PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, Monks Investment Trust PLC (MNKS.L) currently holds an overall rank of #252 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include valuation (P/E 4.8, dividend yield 0.0%), where it demonstrates compelling valuation metrics, trading at a discount to peer averages on key multiples; technical (RSI 71.4), where it demonstrates positive technical momentum with price action supporting a constructive trend; and profitability (ROE 26.1%, net margin 96.7%), where it demonstrates strong profitability metrics, ranking in the top quartile for earnings quality and return on capital.

Areas requiring attention include liquidity, where thin trading volumes could increase transaction costs and slippage, as well as solvency (debt/equity 0.1), where balance sheet metrics are unexceptional and offer limited downside protection.

Within the Financials sector, Monks Investment Trust PLC sits at composite rank #252, trailing the Financials peer average (rank 8). It ranks behind all 6 tracked Financials peers in our model.

Despite its mid-table composite rank of #252, Monks Investment Trust PLC shows selective strength — notably in valuation and technical — suggesting a stock with identifiable merits alongside clear areas for improvement.

Strongest Factors

  • Valuation — Rank 18/280 (top quartile)
  • Technical — Rank 42/280 (top quartile)
  • Profitability — Rank 47/280 (top quartile)

Weakest Factors

  • Liquidity — Rank 272/280 (below average)
  • Solvency — Rank 165/280 (middle of the pack)

Score Analysis

Monks Investment Trust PLC is ranked #252 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

104/280
Average Score
Liquidity
Weak272/280
Valuation
Excellent18/280
Profitability
Excellent47/280
Solvency
Fair165/280
Asset Efficiency
Fair126/280
Mkt Trading
Excellent56/280
Technical
Excellent42/280

1. Liquidity

Score: 272/280

How liquid is MNKS and can it meet its short-term obligations?

0/6
liquidity criteria met
–
Quick RatioN/A
Range: N/A
–
Current Ratio0.32x
Range: N/ARank 230/280
–
TTM Operating Cash Flow0.04x
Range: N/ARank 215/280
–
Liquidity Coverage RatioN/A
Range: 100-150
–
Intangible Asset RatioN/A
Range: 10 - 30Rank 193/280
–
Cash-to-Debt Ratio0.08x
Range: N/ARank 208/280

Key Liquidity Metrics

Quick Ratio
N/A
Sector: N/A
Current Ratio
0.32x
Sector: N/A

Overall Liquidity Rank

Rank within universe#272/280
Best (1)Worst (280)

2. Valuation

Score: 18/280

Is MNKS undervalued compared to its peers and fair value metrics?

2/7
valuation criteria met
–
FY27e P/EN/A
Range: 8x - 18x
–
FY26e P/EN/A
Range: 8x - 18x
–
FY27e Net Div Yld (%)N/A
Range: 3.0 - 8.0
✗
Div Payout Ratio0.12%
Range: 30 - 55Rank 50/280
–
Current EV/EBITDA4.1x
Range: N/ARank 39/280
✓
Current P/TBV0.96x
Range: 0.8x - 2.0xRank 74/280
✓
Current P/B0.96x
Range: 0.8x - 2.0xRank 86/280

Key Valuation Metrics

TTM P/E
Price-to-Earnings
4.8x
FY26e P/E
Forward estimate
N/A
FY27e P/E
Forward estimate
N/A
Current P/B
Price-to-Book
0.96x
Current P/TBV
Tangible Book Value
0.96x
Current EV/EBITDA
Enterprise Value
4.1x
FY26e EV/EBITDA
Forward estimate
N/A
FY27e EV/EBITDA
Forward estimate
N/A

Dividend

MNKS pays a dividend yield of 0.03%.

Current Yield
0.03%
FY27e Net Div Yield
N/A
FY26e Gross DPS
N/A
FY27e Gross DPS
N/A

3. Profitability

Score: 47/280

How profitable is MNKS relative to its peers?

0/7
profitability criteria met
✗
TTM Profit Margin96.7%
Range: 15 - 30Rank 12/280
–
T12 FCF Margin0.0%
Range: N/ARank 203/280
–
FY27e RoEN/A
Range: 10 - 16
–
FY26 EPS GrowthN/A
Range: 8 - 15
–
FY27e EPS GrowthN/A
Range: 6 - 12
–
NIMN/A
Range: 1.5 - 3.2
–
Expense RatioN/A
Range: 50 - 65
TTM Profit Margin
96.7%
Current RoCE
26.1%
FY27e RoE
N/A
T12 FCF Margin
0.0%

4. Solvency

Score: 165/280

How strong is MNKS's balance sheet and financial position?

0/6
solvency criteria met
✗
Debt/Eqt0.09x
Range: 0.5x - 1.5xRank 58/280
–
Interest Coverage RatioRank 31
Range: N/ARank 31/280
–
Net Leverage RatioN/A
Range: N/A
–
Altman Z-Score (Manufacturing)-1125.86
Range: N/ARank 280/280
–
Z-Score (Non Manufacturing)Rank 280
Range: N/ARank 280/280
–
CapAdeq Ratio Tier1N/A
Range: 13 - 18

Key Solvency Metrics

Debt/Eqt
0.09x
Net Leverage Ratio
N/A
Interest Coverage
Rank 31
T12 FCF Margin
0.0%

Altman Z-Score

-1125.86
Distress Zone
01.812.995+

5. Asset Efficiency

Score: 126/280

How efficiently does MNKS deploy its assets and intellectual capital?

0/5
asset efficiency criteria met
–
Efficiency RatioN/A
Range: 50 - 70
–
TTM Asset Turnover Ratio0.25x
Range: N/ARank 172/280
–
TTM CAPEX/SalesN/A
Range: 1 - 3
–
Working Capital TurnoverN/A
Range: N/A
–
R&D/Sales FY27eN/A
Range: N/A

Overall Asset Efficiency Rank

Rank within sector peers#126/280
Best (1)Worst (280)

6. Market Trading

Score: 56/280

How liquid and actively traded is MNKS?

0/2
market trading criteria met
–
Intraday Sentiment (%)N/A
Range: 40 - 75
–
10D-Avg v/s 3M-Avg Vol106%
Range: N/ARank 50/280
✗
Avg Directional Index 30D11.4
Range: 012 - 45Rank 269/280
–
Parabolic SAR1687.13
Range: N/ARank 65/280
–
Stock Rating RankN/A
Range: N/A
Market Cap
£2,513,916,775
Enterprise Value
£2,719,731,242

Trading Volume

7. Technical

Score: 42/280

What do the technical indicators say about MNKS?

0/5
technical criteria met
–
CMP v/s 52-WH-0.8%
£16.96£13.66
-0.8%CMP: £16.82
Range: N/ARank 12/280
–
CMP v/s 52-WL23.1%
£16.96£13.66
+23.1%CMP: £16.82
Range: N/ARank 134/280
–
RSI 14D71.4
071.4 - Overbought100
Range: N/ARank 25/280
–
MA50 - MA200Bullish
£15.64+0.64£16.28
Range: N/ARank 68/280
–
MACD Rank4.33
Golden Cross
MACD: 4.33
Range: N/ARank 100/280

RSI (14 Day)

71.4
Overbought
0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£16.28
200 SMA£15.64
SignalGolden Cross (Bullish)
MACD4.33

Risk Metrics

Beta
N/A
3-Yr Std Dev
N/A
5-Yr Std Dev
N/A

Peer Comparison

How does MNKS compare to other Financials stocks?

Overall Rank Comparison

Factor Score Comparison

StockRankLiquidityValuationProfitabilitySolvencyMkt TradingTechnical
MNKS#25227218471655642
MUT.L#3128382456278
RTW.L#51167914569229
BPCR.L#71633456911276
RCP.L#9179262259132
AGT.L#111085755729079
TBCG.L#1429553825712918
Sponsored
Healthcare Discovery Monitor
Live
Healthcare Discovery Monitor
Healthcare Discovery Monitorby StrategyLand

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

10+
Sources
4
Markets
12h
Cycle
50+
Keywords
USUKCNEU
Launch Monitor

Methodology Note

The analysis presented for Monks Investment Trust PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Note: The information provided is not intended as an offer or solicitation for the purchase or sale of any financial instruments but for investor relations purposes only. The aforementioned securities were offered to the public and currently trade on the secondary market at the exchange mentioned above. It is recommended that investors considering investing in any of these notes consult an approved MiFID Financial Advisor prior to investing.